Find uplifting stories about heroes, innovations, and solutions
20 results for "lenacapavir"
Nigeria just introduced a twice-yearly HIV injection that could replace daily pills and help eliminate AIDS within six years. The breakthrough treatment, called Lenacapavir, offers new hope for millions while reducing stigma and improving care access.
South Africa just received its first shipment of Lenacapavir, a revolutionary HIV prevention injection that works for six months with a single dose. The breakthrough treatment could transform protection for vulnerable communities who struggle with daily prevention methods.
South Africa just received its first shipment of a revolutionary HIV prevention medication that requires just two shots per year. In a country where 8.15 million people live with HIV, this could transform prevention efforts.
South Africa just received 38,000 doses of a breakthrough HIV prevention injection that works for six months with just two shots per year. The country is the first in Africa to approve and roll out Lenacapavir, potentially transforming prevention for millions.
A twice-yearly shot prevents HIV with 100% effectiveness, but its $28,000 price tag keeps it out of reach. A proven "subscription pricing" model could make it accessible to everyone who needs it.
Nigeria becomes one of nine countries to offer Lenacapavir, a groundbreaking HIV prevention injection needed just twice a year instead of daily pills. The first 52,000 doses will reach vulnerable populations across eight states, offering a discreet new path to staying HIV-free.
Nigeria will receive nearly 180,000 doses of a groundbreaking HIV prevention drug that requires just two injections per year instead of daily pills. The country is among nine nations worldwide launching the treatment simultaneously, a first in the fight against HIV.
South Africa will begin rolling out a groundbreaking HIV prevention injection in May that only requires two doses per year. The new treatment could transform how the country protects millions of people at risk of infection.
South Africa is partnering with global health organizations to manufacture a revolutionary twice-yearly HIV injection that could help end the pandemic. The move could bring lifesaving medication to 8 million South Africans living with HIV and millions more across the continent.
Nigeria will receive a groundbreaking HIV prevention injection that works for six months with just two doses per year, making protection more accessible than ever. The new drug arrives in March 2026 as part of the country's ambitious plan to end the HIV epidemic.
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Kenya becomes the first country to roll out Lenacapavir, a groundbreaking injection that prevents HIV for six months with a single shot. The breakthrough could dramatically reduce the country's 20,000 annual new infections by eliminating daily pill routines.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention drug that requires just two injections per year, completely free to those who need it most. The move brings new hope to 1.4 million Kenyans living with HIV and vulnerable young people facing the highest risk of infection.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention injection that protects people for six months with a single shot. The treatment is completely free and could change the lives of 1.4 million Kenyans living with HIV.
Kenya began administering a groundbreaking HIV prevention injection that's taken just twice a year and reduces transmission risk by more than 99.9 percent. The drug is free for recipients, offering new hope to 1.3 million Kenyans living with HIV.
A revolutionary HIV prevention shot that only requires two doses per year is coming to 271,000 people in Zimbabwe, backed by US support that could prevent more than 9,000 new infections. The groundbreaking injection removes daily pill barriers and offers a new path toward an AIDS-free generation.
Kenya just received its first shipment of Lenacapavir, a groundbreaking HIV prevention treatment that requires just two injections per year instead of daily pills. The new option could dramatically reduce infections among pregnant and breastfeeding women, who face the highest risk.
%2Ffile%2Fattachments%2Forphans%2FFEATUREIMAGE1_176820.jpg)
Starting April 1st, nearly half a million South Africans can access a groundbreaking HIV prevention injection that requires just two doses per year and has shown 100% effectiveness in trials. The free rollout could help end AIDS as a public health threat by 2043.
A twice-yearly injection prevented every single HIV infection in a major clinical trial, offering new hope for Nigeria's 1.9 million people living with HIV. The challenge now is making this breakthrough affordable and accessible to those who need it most.
Scientists discovered that when HIV develops resistance to the breakthrough drug lenacapavir, the virus becomes significantly weaker and struggles to survive. This finding shows the medication is working even better than expected.